Zykadia (ceritinib) - Novartis
Augtyro (repotrectinib) - BMS
Rozlytrek (entrectinib) - Roche
Xalkori (crizotinib) - Pfizer
Lorbrena (lorlatinib) - Pfizer
Cabometyx (cabozantinib tablet) - Exelixis
Alunbrig (brigatinib) - Takeda
http://www.ncbi.nlm.nih.gov/pubmed/42769117
 
Hao Zhong; Xingjun Huang; Yige Yu; Yingyu Yu; Yongjian Liu
 
Sep 23, 2026
 
Prev Next